FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2066680933> ?p ?o ?g. }

• W2066680933 endingPage "3385" @default.
• W2066680933 startingPage "3375" @default.
• W2066680933 abstract "Excessive generation of reactive oxygen species (ROS) in cancer cells is associated with cancer development, but the underlying mechanisms and therapeutic significance remain elusive. In this study, we reported that levels of ROS and p22phox expression are greatly increased in human prostate cancer tissues, and knockdown of p22phox by specific small interfering RNA (siRNA) decreased ROS levels in prostate cancer cells. We also showed that stable downregulation of p22phox in prostate cancer cells inhibited cell proliferation and colony formation, which was mediated by AKT and extracellular signal-regulated kinase (ERK)1/2 signaling pathways and their downstream molecules hypoxia-inducible factor 1α (HIF-1α) and vascular endothelial growth factor (VEGF). The NADPH oxidase subunit NOX1 was also elevated in prostate cancer cells, and was involved in activation of AKT/ERK/HIF-1/VEGF pathway and regulation of cell proliferation. Knockdown of p22phox resulted in inhibition of tumor angiogenesis and tumor growth in nude mice. These findings reveal a new function of p22phox in tumor angiogenesis and tumor growth, and suggest that p22phox is a potential novel target for prostate cancer treatment." @default.
• W2066680933 created "2016-06-24" @default.
• W2066680933 creator A5002100940 @default.
• W2066680933 creator A5009273014 @default.
• W2066680933 creator A5015102287 @default.
• W2066680933 creator A5019524490 @default.
• W2066680933 creator A5020746135 @default.
• W2066680933 creator A5029356151 @default.
• W2066680933 creator A5053401529 @default.
• W2066680933 creator A5055653838 @default.
• W2066680933 creator A5065023946 @default.
• W2066680933 creator A5065798455 @default.
• W2066680933 creator A5071290555 @default.
• W2066680933 creator A5074904959 @default.
• W2066680933 creator A5075394139 @default.
• W2066680933 creator A5081687805 @default.
• W2066680933 creator A5086498115 @default.
• W2066680933 date "2013-12-01" @default.
• W2066680933 modified "2023-10-18" @default.
• W2066680933 title "NADPH oxidase subunit p22 phox -mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer" @default.
• W2066680933 cites W1586159393 @default.
• W2066680933 cites W1963723155 @default.
• W2066680933 cites W1965723149 @default.
• W2066680933 cites W1968422325 @default.
• W2066680933 cites W1974997758 @default.
• W2066680933 cites W1975419073 @default.
• W2066680933 cites W1978139448 @default.
• W2066680933 cites W1983763042 @default.
• W2066680933 cites W1993552192 @default.
• W2066680933 cites W2008294451 @default.
• W2066680933 cites W2009886463 @default.
• W2066680933 cites W2011993914 @default.
• W2066680933 cites W2015088673 @default.
• W2066680933 cites W2017079479 @default.
• W2066680933 cites W2020822273 @default.
• W2066680933 cites W2021469759 @default.
• W2066680933 cites W2025141680 @default.
• W2066680933 cites W2027575634 @default.
• W2066680933 cites W2039666546 @default.
• W2066680933 cites W2041811289 @default.
• W2066680933 cites W2043315157 @default.
• W2066680933 cites W2046867705 @default.
• W2066680933 cites W2048725147 @default.
• W2066680933 cites W2057106513 @default.
• W2066680933 cites W2066170631 @default.
• W2066680933 cites W2068427129 @default.
• W2066680933 cites W2068578399 @default.
• W2066680933 cites W2069096268 @default.
• W2066680933 cites W2072174276 @default.
• W2066680933 cites W2082227406 @default.
• W2066680933 cites W2085128107 @default.
• W2066680933 cites W2087650169 @default.
• W2066680933 cites W2103558787 @default.
• W2066680933 cites W2110177672 @default.
• W2066680933 cites W2112849045 @default.
• W2066680933 cites W2114098415 @default.
• W2066680933 cites W2114773893 @default.
• W2066680933 cites W2121168477 @default.
• W2066680933 cites W2132270233 @default.
• W2066680933 cites W2132399579 @default.
• W2066680933 cites W2133665922 @default.
• W2066680933 cites W2142325703 @default.
• W2066680933 cites W2147247243 @default.
• W2066680933 cites W2149262191 @default.
• W2066680933 cites W2150414251 @default.
• W2066680933 cites W2159127121 @default.
• W2066680933 cites W2163069245 @default.
• W2066680933 cites W2166562646 @default.
• W2066680933 cites W2170069804 @default.
• W2066680933 cites W2319962899 @default.
• W2066680933 cites W274236614 @default.
• W2066680933 doi "https://doi.org/10.1016/j.bbamcr.2013.09.018" @default.
• W2066680933 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24113386" @default.
• W2066680933 hasPublicationYear "2013" @default.
• W2066680933 type Work @default.
• W2066680933 sameAs 2066680933 @default.
• W2066680933 citedByCount "39" @default.
• W2066680933 countsByYear W20666809332014 @default.
• W2066680933 countsByYear W20666809332015 @default.
• W2066680933 countsByYear W20666809332016 @default.
• W2066680933 countsByYear W20666809332017 @default.
• W2066680933 countsByYear W20666809332018 @default.
• W2066680933 countsByYear W20666809332019 @default.
• W2066680933 countsByYear W20666809332020 @default.
• W2066680933 countsByYear W20666809332021 @default.
• W2066680933 countsByYear W20666809332022 @default.
• W2066680933 crossrefType "journal-article" @default.
• W2066680933 hasAuthorship W2066680933A5002100940 @default.
• W2066680933 hasAuthorship W2066680933A5009273014 @default.
• W2066680933 hasAuthorship W2066680933A5015102287 @default.
• W2066680933 hasAuthorship W2066680933A5019524490 @default.
• W2066680933 hasAuthorship W2066680933A5020746135 @default.
• W2066680933 hasAuthorship W2066680933A5029356151 @default.
• W2066680933 hasAuthorship W2066680933A5053401529 @default.
• W2066680933 hasAuthorship W2066680933A5055653838 @default.
• W2066680933 hasAuthorship W2066680933A5065023946 @default.
• W2066680933 hasAuthorship W2066680933A5065798455 @default.
• W2066680933 hasAuthorship W2066680933A5071290555 @default.

• next